Rite Aid Corp (RAD)
$12.42 0.00 (0.00%)
19:59 EDT RAD Stock Quote Delayed 30 Minutes
Previous Close $12.42
Market Cap 13.25B
PE Ratio -36.53
Volume (Avg. Vol.) 2.35M
Day's Range 12.10 - 12.66
52-Week Range 5.04 - 23.88
Dividend & Yield N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
- From InvestorPlace
- From the Web
Should the economy not bounce back following the coronavirus, you’ll want to look at these recession-resistant stocks to buy.
Investors are rooting for a Rite Aid turnaround, but it looks increasingly unlikely. Sell RAD stock now and look for better opportunities.
Several healthcare stocks have jumped higher based off the coronavirus pandemic. But these nine companies have a longer upside pathway.
RAD stock has stabilized in recent months, but Q4 results show a lack of growth. With disruption on the way, Rite Aid may be left behind.
Morgan Stanley, Shopify, Snap and Rite Aid were our top stock trades for Friday. That said, here's a look at the charts now.
Jobless claims data continues to paint an uninspiring outlook on the U.S. economy. Here's what happened in the stock market today.
Rite Aid (RAD) earnings for the drugstore company's fiscal fourth quarter of 2020 have RAD stock taking a beating on Thursday.
Rite Aid has been taking steps to serve customers and healthcare workers more effectively in the national battle against the outbreak. But will they translate into higher earnings in April?
The M&A market could bounce back in 2020, and as it does, investors should keep an eye on these seven buyout targets.
These stocks have defied the 2020 selloff. This means they may be stocks to buy for investors betting a broad market bottom is on the way.
RAD stock has rallied nicely — and for good reason. While debt remains a key risk, there are positive developments worth highlighting.
CEO-led turnaround has made RAD stock very valuable, and cheap based on 2020 outlook, as firm fundamentals lead to a higher stock price.
RAD stock is trading as if the Rite Aid turnaround is a certainty, but it's anything but that, and that makes the stock quite risky.
Roku and Nvidia earnings previews, plus Centurylink, Rite Aid and Microsoft were our top stock trades for Friday.
RAD stock jumped higher off a strong Q4 earnings beat but without a viable recovery narrative. This is where the story ends.
There's an old investment saying that goes something like (forgive my paraphrasing) “credit leads equity.” What that means is that a company's corporate debt can be a tell about future price action in the stock. Rite Aid recently exchanged $600 million in notes coming due in 2023 for notes maturing in 2025. While that move will help with interest expense, at least one ratings agency doesn't see a reason to upgrade the company's flimsy credit rating.
Rite Aid is still a risky play, but the technicals finally look attractive and the fundamentals are improving for RAD stock.
Rite Aid shares have been seized with volatility, making RAD stock a toss-up play for bears and bulls alike.
From Analyst Ratings
In a report released today, Joseph Foresi from Cantor Fitzgerald maintained a Hold rating on Syntel (NASDAQ: SYNT), with a price target of $41. The company’s shares closed yesterday at $40.68, close to its 52-week high of $40.89. Foresi observed: “. We maintain our Neutral rating on Syntel and our PT at $41. We continue
Navellier RatingsPowered by Portfolio Grader